Pro-Dex, Inc.

Informe acción NasdaqCM:PDEX

Capitalización de mercado: US$64.6m

Pro-Dex Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Pro-Dex ha aumentado sus beneficios a una tasa media anual de 5.9%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 13.5% anual. Los ingresos han ido creciendo a una tasa media de 12.6% al año. La rentabilidad financiera de Pro-Dex es de 9.5%, y sus márgenes netos son de 6.2%.

Información clave

5.9%

Tasa de crecimiento de los beneficios

9.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment 8.9%
Tasa de crecimiento de los ingresos12.6%
Rentabilidad financiera9.5%
Margen neto6.2%
Última actualización de beneficios31 Dec 2023

Actualizaciones de resultados anteriores recientes

Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality

Feb 16
Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality

Recent updates

Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality

Feb 16
Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality

Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly

Feb 14
Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly

Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jan 24
Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet

May 20
Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet

Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital

Oct 05
Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital

Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting

Sep 26

When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?

Sep 20
When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?

Pro-Dex GAAP EPS of $0.38, revenue of $12.61M

Aug 25

Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

May 10
Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?

Apr 21
Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?

Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price

Mar 14
Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price

Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?

Feb 09
Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?

We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt

Nov 17
We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

Aug 29
Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

A History Of Strong Growth Rates: Pro-Dex On Sale

Aug 25

The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising

May 18
The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising

What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Mar 29
What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 15
Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted

Feb 26
The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted

Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)

Feb 13
Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)

We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)

Feb 08
We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)

Pro-Dex EPS misses by $0.27, misses on revenue

Feb 04

Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?

Jan 25
Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?

What Is The Ownership Structure Like For Pro-Dex, Inc. (NASDAQ:PDEX)?

Jan 11
What Is The Ownership Structure Like For Pro-Dex, Inc. (NASDAQ:PDEX)?

How Much Are Pro-Dex, Inc. (NASDAQ:PDEX) Insiders Taking Off The Table?

Dec 28
How Much Are Pro-Dex, Inc. (NASDAQ:PDEX) Insiders Taking Off The Table?

With EPS Growth And More, Pro-Dex (NASDAQ:PDEX) Is Interesting

Dec 14
With EPS Growth And More, Pro-Dex (NASDAQ:PDEX) Is Interesting

What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Nov 30
What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Pro-Dex. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

NasdaqCM:PDEX Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Dec 2348352
30 Sep 2347552
30 Jun 2346752
31 Mar 2348752
31 Dec 2244752
30 Sep 2243562
30 Jun 2242562
31 Mar 2239353
31 Dec 2141563
30 Sep 2139664
30 Jun 2138654
31 Mar 2140853
31 Dec 2036753
30 Sep 2036642
30 Jun 2035642
31 Mar 2031432
31 Dec 1929432
30 Sep 1927432
30 Jun 1927432
31 Mar 1926332
31 Dec 1825332
30 Sep 1824232
30 Jun 1822232
31 Mar 1822232
31 Dec 1723232
30 Sep 1722531
30 Jun 1722531
31 Mar 1721431
31 Dec 1620431
30 Sep 1620231
30 Jun 1619131
31 Mar 1618131
31 Dec 1517031
30 Sep 1515032
30 Jun 1513032
31 Mar 1513032
31 Dec 1411-122
30 Sep 1411-121
30 Jun 1411-121
31 Mar 1410-132
31 Dec 1311-232
30 Sep 1311-232
30 Jun 1312-242

Ingresos de calidad: PDEX tiene un gran one-off loss de $1.9M impacto en sus últimos 12 meses de resultados financieros a 31st December, 2023.

Margen de beneficios creciente: Los actuales márgenes de beneficio(6.2%) de PDEX son inferiores a los del año pasado (14.8%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de PDEX han crecido un 5.9% al año en los últimos 5 años.

Acelerando crecimiento: PDEX ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: PDEX tuvo un crecimiento negativo de los beneficios (-54.1%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (3.3%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de PDEX (9.5%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target